2020 - Fellow of the American Association for the Advancement of Science (AAAS)
2002 - Fellow of Alfred P. Sloan Foundation
David R. Liu mainly focuses on Computational biology, Genome editing, DNA, Genetics and Cas9. His Computational biology study incorporates themes from Genome, Gene, CRISPR and Small molecule. His Guide RNA study, which is part of a larger body of work in Genome editing, is frequently linked to Software, bridging the gap between disciplines.
His research integrates issues of RNA, Human genome and Point mutation in his study of DNA. His Point mutation study integrates concerns from other disciplines, such as genomic DNA and DNA glycosylase. Many of his studies involve connections with topics such as Protein engineering and Genetics.
David R. Liu mainly investigates Computational biology, DNA, Biochemistry, Genome editing and Genetics. David R. Liu studied Computational biology and Cas9 that intersect with Nuclease. His DNA study also includes
He interconnects HEK 293 cells, Base pair and Human genome in the investigation of issues within Genome editing. His is involved in several facets of Genetics study, as is seen by his studies on Directed evolution, Point mutation and Transcription activator-like effector nuclease. His work carried out in the field of Nucleic acid brings together such families of science as Combinatorial chemistry, Sequence and Polymer.
His primary areas of study are Computational biology, Genome editing, CRISPR, Gene and DNA. His work deals with themes such as RNA, HEK 293 cells and Cas9, Guide RNA, which intersect with Computational biology. His study explores the link between Cas9 and topics such as genomic DNA that cross with problems in Whole genome sequencing.
His studies deal with areas such as Base pair and Dna breaks as well as Genome editing. His DNA research includes elements of Nucleic acid and Deamination. His Point mutation study deals with the bigger picture of Genetics.
His scientific interests lie mostly in Computational biology, Mutation, DNA, Genome editing and Cas9. His Mutation study combines topics in areas such as RNA and Cytosine. His DNA research incorporates themes from Deamination and Guide RNA.
His Guide RNA research entails a greater understanding of Genetics. Genome and CRISPR are the subject areas of his Genome editing study. David R. Liu combines subjects such as HEK 293 cells, Enhancer and Deoxyadenosine with his study of Cas9.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta V. Tahiliani;Kian Peng Koh;Yinghua Shen;William Abraham Pastor.
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Alexis C. Komor;Yongjoo B. Kim;Yongjoo B. Kim;Michael S. Packer;Michael S. Packer;John A. Zuris;John A. Zuris.
DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists
Da Wei Huang;Brad T. Sherman;Qina Tan;Joseph Kir.
Nucleic Acids Research (2007)
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone;Andrew V. Anzalone;Andrew V. Anzalone;Peyton B. Randolph;Peyton B. Randolph;Peyton B. Randolph;Jessie R. Davis;Jessie R. Davis;Jessie R. Davis;Alexander A. Sousa;Alexander A. Sousa;Alexander A. Sousa.
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Eugene D. Kwon;Charles G. Drake;Howard I. Scher;Karim Fizazi.
Lancet Oncology (2014)
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
Vikram Pattanayak;Steven Lin;John P Guilinger;Enbo Ma.
Nature Biotechnology (2013)
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Nicole M. Gaudelli;Alexis C. Komor;Holly A. Rees;Holly A. Rees;Holly A. Rees;Michael S. Packer.
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
John A. Zuris;David B. Thompson;Yilai Shu;John Paul Guilinger.
Nature Biotechnology (2015)
Jean-François Lutz;Makoto Ouchi;David R. Liu;Mitsuo Sawamoto.
A Small Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing Nanog
Justin K. Ichida;Joel Blanchard;Kelvin Lam;Esther Y. Son.
Cell Stem Cell (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: